FBB
BIIB icon

Fulton Breakefield Broenniman’s Biogen BIIB Stock Holding History

Fulton Breakefield Broenniman’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-586
Closed -$203K – 178
2021
Q2 		$203K Buy
+586
New +$178K 0.02% 177
2020
Q2 		– Sell
-666
Closed -$211K – 165
2020
Q1 		$211K Buy
+666
New +$202K 0.03% 145

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fulton Breakefield Broenniman's BIIB Position: Q3 2021 in Review

Fulton Breakefield Broenniman sold out of Biogen (BIIB) in Q3 2021, closing a stake of 586 shares — an estimated $203K sold.

Fulton Breakefield Broenniman first reported a position in BIIB in Q1 2020 and held it in 2 quarters. The position peaked at $211K in Q1 2020. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Fulton Breakefield Broenniman reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 586 Biogen shares in Q3 2021, an estimated $203K.
  • Fulton Breakefield Broenniman first reported a position in Biogen in Q1 2020 and held it in 2 quarters.
  • Fulton Breakefield Broenniman's Biogen position peaked at $211K in Q1 2020.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Fulton Breakefield Broenniman's 13F filing for Q3 2021, filed 25 Oct 2021.